The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Danilov A.B.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Glembotskaia G.T.

Kozub O.V.

Pharmacoeconomic aspects of migraine

Authors:

Danilov A.B., Glembotskaia G.T., Kozub O.V.

More about the authors

Read: 616 times


To cite this article:

Danilov AB, Glembotskaia GT, Kozub OV. Pharmacoeconomic aspects of migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(4):79‑81. (In Russ.)

Recommended articles:
Oxidative stress in the pathogenesis of chro­nic headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):35-40
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):21-26
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75

References:

  1. Danilov A.B. Optimizatsiya lecheniya ostrykh pristupov migreni 2008
  2. Rachin A.P., Osipova V.V., Yudel'son Ya.B. Migren': ot pravil'noi diagnostiki k adekvatnoi terapii. Spravochnik poliklinicheskogo vracha 2007; 1.
  3. Yagudina R.I., Kulikov A.Yu. Farmakoekonomika: obshchie svedeniya, metody issledovaniya. Novaya apteka 2007; 9: 73-78.
  4. Yakhno N.N. Differentsirovannaya taktika lecheniya pristupov migreni. Meditsina dlya vsekh 1998; 4: 7-9.
  5. Andlin-Sobocki P., Jonsson B., Wittchen H.-U., Olesen J. Cost of disorders of the brain in Europe. European Jornal of Neurology 2005; 1: 12: 1-27.
  6. Bigal M.E., Rapaport A.M., Bordini C.A. et al. Burden of migraine in Brazil: estimate of costs to the public health system and an analytical study of the cost-effectiveness of a stratified model of care. Headache 2003; 43: 7: 742-754.
  7. Clarke C.E., Mac Millan L., Sondhi S., Wells N.E. Economic and social impact of migraine. Q J Med 1996; 89: 77-84.
  8. Evers S., Afra J., Frese A. et al. EFNS guideline on the drug treatment of migraine. European Journal of Neurology 2006; 13: 560-572.
  9. Launer L.J., Terwindt G.M., Ferrari M.D. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999; 53: 537-542.
  10. Lawrence D. The Cost of Migraine and Its Treatment. The American Journal of Managed Care 2005; 11: 62-67.
  11. Lipton R.B., Diamond S., Reed M. et al. Migraine diagnosis and treatment; resalts from American Migraine Study II. Headache 2001; 41: 638-645.
  12. Lipton R.B., Stewart W.F., Diamond S. et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41: 646-657.
  13. Sculpher M., Millson D., Meddis D., Poole L. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: the Disability in Strategies for Care (DISC) study. Pharmacoeconomics 2002; 20: 91-100.
  14. Steiner T.J. et al. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalgia 2003; 23: 519-527.
  15. Stovner L.J., Hagen K., Jensen R. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephaiaigia 2007; 27: 193-210.
  16. Vreeland M.G. The Economic Burden of Migraine: The Role of the Triptans. The American Journal of Managed Care 1998; 4: 630-632.
  17. Williams P., Dowson A.J., Rapoport A.M., Sawyer J. The cost-effectiveness of stratified care in the management of migraine. Pharmacoeconomics 2001; 19: 819-829.
  18. World Health Organization. World health report 2001. Geneva: WHO 2001; 22-24.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.